Curative Ventures
Venture capitalDallas
Also known as CURATIVE VENTURES MANAGEMENT LLC
Investment thesis
Curative Ventures backs category-defining biotech companies working on novel therapies designed to dramatically improve patient outcomes. Acting as both a capital and talent partner, the firm supports companies advancing new treatments across areas such as oncology and other therapeutic domains. Its investment activity, evidenced by companies like Instil Bio, Peloton Therapeutics, Exonics, and TCR2 Therapeutics, spans developments through IPOs and acquisitions.
Source: firm website, verified Aug 25, 2026.
What they invest in
from 1 of 5 portfolio companiesBiotech Γ1
HQs:United StatesΓ1
Investments Β· 5 tracked
founders shown can be your intro path
Instil Bio is a biotechnology company that identifies and develops therapeutic opportunities.
BiotechDallas, US
Bronson Crouch(Chief Executive Officer & Chairman of the Board)Sandeep "Steve" Laumas(Chief Financial Officer & Chief Business Officer)Nimish Shah(Director)Gwen Binder(Director)Neil Gibson(Director)George Matcham(Director)
Co-investorsVivo Capital
Duchenne muscular dystrophy therapy developer acquired by Vertex.
Oncology company developing an oral HIF-2Ξ± inhibitor; acquired by Merck.
Cell therapy company that priced an IPO.
Exits Β· 3
IPOs and acquisitions across the tracked portfolioInstil BioNASDAQ: TILExonicsacq. by VertexPeloton Therapeuticsacq. by Merck
Portfolio news
latest coverage across their companiesInstil Bio Β· stocktitan.net Β· May 15, 2026
Frequently asked questions
- How many investments has Curative Ventures made?
- Curative Ventures has 6 tracked investments, 3 of which have exited via acquisition or IPO.
- What sectors does Curative Ventures focus on?
- Curative Ventures focuses on Biotech.
- Where is Curative Ventures located?
- Curative Ventures is headquartered in Dallas, US.
Similar investors
8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.
ACT Venture Capital is an independent Irish venture capital firm that invests β¬1 million to β¬15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
Andreessen Horowitz (a16z) is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz, known for pioneering the platform model with a large team of operators supporting founders across stages.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.